![]() |
市場調查報告書
商品編碼
1497610
醫療保健人工智慧市場:按技術、服務、應用程式和最終用戶分類 - 全球預測 2024-2030Artificial Intelligence in Healthcare Market by Technology (Computer Vision, Context-Aware Computing, Machine Learning), Offering (Hardware, Services, Software), Application, End User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
醫療保健領域人工智慧市場規模預計2023年為259.1億美元,2024年達到324.8億美元,預計2030年將達到1377.4億美元,複合年成長率為26.95%。
醫療保健領域的人工智慧 (AI) 是使機器能夠感知、理解、行動和學習的技術的集合。這包括可以處理醫療資料、預測結果、支持精準醫療和個人化患者照護的演算法和模型。推動人工智慧在醫療保健領域擴展的主要因素是醫療保健資料的大量增加、降低醫療成本上升的需要、計算能力的進步以及人工智慧演算法的改進。這些因素有助於提高治療、藥物發現和患者照護管理的效率。然而,資料安全問題、侵犯隱私的風險以及對人工智慧基礎設施的大量投資的需求正在阻礙人工智慧的廣泛普及。強力的網路安全措施、人工智慧演算法的透明管治、持續的員工培訓以及人工智慧系統的道德設計對於解決這些問題至關重要。利用人工智慧推進遠端醫療、預測分析、開拓個人化治療計劃,以及將人工智慧與基因組學和醫療物聯網 (IoMT) 等新興技術相結合,預計將推動 Masu 市場的顯著成長。
主要市場統計 | |
---|---|
基準年[2023] | 259.1億美元 |
預測年份 [2024] | 324.8億美元 |
預測年份 [2030] | 1377.4億美元 |
複合年成長率(%) | 26.95% |
區域洞察
在大量技術投資、充滿活力的Start-Ups生態系統以及鼓勵數位醫療創新的政策舉措的推動下,美洲(尤其是美國)醫療保健領域的人工智慧市場正在蓬勃發展。美國是人工智慧診斷、遠端監控和個人化醫療領域的先驅,科技巨頭和人工智慧醫療保健專家正在推動進步。以中國和日本為代表的亞太地區政府對醫療保健創新給予大力支持,並正迅速擁抱人工智慧。鑑於人口眾多以及改善醫療保健機會的動力,其使用往往側重於大規模人口健康舉措和疾病模式分析。在亞太地區,由於國內新興企業的激增和全球公司研發中心的擴張,生產變得越來越強勁。雖然歐洲在法律規範方面處於領先地位,並且 GDPR 影響了人工智慧的採用,但中東在智慧醫院和人工智慧驅動的健康工具方面顯示出巨大的成長潛力。儘管非洲仍處於採用的早期階段,但它顯示了行動醫療人工智慧應用在解決感染疾病和獲得醫療服務方面的潛力。歐洲、中東和非洲地區的公司專注於開發合規和道德的人工智慧,一些領先公司提供先進的基於人工智慧的診斷成像和健康分析解決方案。
FPNV定位矩陣
FPNV 定位矩陣對於評估醫療保健市場人工智慧供應商的市場定位至關重要。此矩陣提供了對供應商的全面評估,並檢查了與商務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可對醫療保健市場人工智慧供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該行業競爭性質的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在醫療保健市場人工智慧中的地位進行全面評估,使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[188 Pages Report] The Artificial Intelligence in Healthcare Market size was estimated at USD 25.91 billion in 2023 and expected to reach USD 32.48 billion in 2024, at a CAGR 26.95% to reach USD 137.74 billion by 2030.
Artificial intelligence (AI) in healthcare represents a collection of multiple technologies enabling machines to sense, comprehend, act, and learn so that they can perform administrative and clinical healthcare functions. It includes algorithms and models that are capable of processing medical data, predicting outcomes, aiding in precision medicine, and personalizing patient care. Major factors driving the expansion of AI in healthcare are the massive growth of healthcare data, the need to reduce escalating healthcare costs, advancements in computing power, and the improvement in AI algorithms. These factors contribute to enhancing the efficiency of treatments, drug discovery, and patient care management. However, data security concerns, the risk of privacy breaches, and the requirement for substantial investment in AI infrastructure impede their wide deployment. To address these issues, robust cybersecurity measures, transparent governance of AI algorithms, ongoing staff training, and the ethical design of AI systems are essential. The market is expected to witness significant growth by leveraging AI for telemedicine advancements, predictive analytics, the development of personalized treatment plans, and the integration of AI with emerging technologies such as genomics and the Internet of Medical Things (IoMT).
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 25.91 billion |
Estimated Year [2024] | USD 32.48 billion |
Forecast Year [2030] | USD 137.74 billion |
CAGR (%) | 26.95% |
Regional Insights
In the Americas, especially the United States, there is a booming market for AI in healthcare, driven by heavy investments in technology, a vibrant startup ecosystem, and policy initiatives encouraging digital health innovation. The U.S. is a pioneer in AI-driven diagnostics, remote monitoring, and personalized medicine, with tech giants and specialized AI healthcare companies pushing advancements. The APAC region, led by countries such as China and Japan, is rapidly embracing AI, with significant government backing for healthcare technology innovation. The focus on use tends toward large-scale population health initiatives and disease pattern analysis, given the vast population and the drive towards improving healthcare accessibility. Production is increasingly robust in APAC, with a surge in homegrown startups and expanded R&D centers from global companies. Europe leads in regulatory frameworks with GDPR impacting AI deployment, whereas the Middle East shows considerable growth potential with smart hospitals and AI-powered health tools. Africa is still in the early adoption stages, but it shows potential in mobile health AI applications that address infectious diseases and access to medical services. Companies in EMEA are focused on compliance and ethical AI development, with some leading enterprises offering advanced AI-based imaging and health analytics solutions.
Market Insights
The market dynamics represent an ever-changing landscape of the Artificial Intelligence in Healthcare Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Artificial Intelligence in Healthcare Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Artificial Intelligence in Healthcare Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
GE HealthCare Launches AI-Powered Innovations to Shape the Future of Healthcare
GE HealthCare introduced 19 advanced innovations in AI-enhanced systems, including the Omni Legend PET/CT scanner for impeccable diagnostic accuracy and the patient-centric SIGNA Champion MRI, which are poised to redefine diagnostic processes and patient experiences. Additionally, clinic workflow efficiency is anticipated to soar with GE's Portrait VSM and the portable yet powerful Vscan Air SL for rapid cardiac and vascular assessments. [Published On: 2024-01-29]
HEALWELL AI to Acquire Intrahealth to Create Next Generation AI-powered EHR
HEALWELL AI Inc. announced its acquisition of Intrahealth Systems Limited from WELL Health Technologies Corp. With Intrahealth's substantial professional network and its forecast to produce significant revenue and high gross margins in 2024, the acquisition promises to be a transformative combination for delivering advanced clinical decision support and shaping the trajectory of value-based care globally. [Published On: 2024-01-25]
HEALWELL AI Completes Acquisition of 'Pentavere,' a Healthcare AI and Data Science Company
HEALWELL AI Inc. enriched its portfolio by acquiring a significant stake in Pentavere Research Group Inc., a Toronto-based pioneer in health-tech AI. Through this strategic move, HEALWELL incorporates Pentavere's technology for data abstraction and structuring, reinforcing its mission to enhance preventative care. [Published On: 2023-12-04]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Artificial Intelligence in Healthcare Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Artificial Intelligence in Healthcare Market, highlighting leading vendors and their innovative profiles. These include Ada Health GmbH, AiCure, LLC, AllStripes Research Inc., Aspen Technology Inc. by Emerson Electric Co., Atomwise Inc., Augmedix, Inc., Babylon Healthcare Services Ltd., Behold.ai Technologies Limited, Binah.ai, BioSymetrics Inc., BPGbio Inc., Butterfly Network, Inc., Clarius Mobile Health Corp., Clinithink Limited, ClosedLoop.ai Inc., Corti ApS, Cyrcardia Asia Limited, Datature.io, Deep Genomics Incorporated, Diabeloop SA, Enlitic, Inc., GE Healthcare, General Vision Inc., Google, LLC by Alphabet, Inc., iCarbonX, Intel Corporation, International Business Machines Corporation, Koninklijke Philips N.V., Medasense Biometrics Ltd., Microsoft Corporation, Modernizing Medicine, Inc., Nanox Imaging Ltd., NetBase Quid, Inc., Novo Nordisk A/S, NVIDIA Corporation, Oncora Medical, Oracle Corporation, Owkin, Inc., Oxipit.ai, R1 RCM, Inc., Recursion Pharmaceuticals, Sanofi SA, Sensely, Inc., Shanghai Yitu Technology Co., Ltd., Siemens Healthineers AG, SkinvVision B.V., Subtle Medical, Inc., Tempus Labs, Inc., Turbine Ltd., and Woebot Health.
Market Segmentation & Coverage